Valérie Molinier-Frenkel

Institut Mondor de Recherche Biomédicale

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

SciProfiles

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Institut Mondor de Recherche Biomédicale

Research Subjects

Research Interests

Valérie Molinier-Frenkel has a total of 128 co-authors. Here are the top co-authors by number of shared publications:

Flavia Castellano
IMRB (INSERM U955) Team Immunoregulation and Biotherapy, Créteil, F-94010 France
18 shared publications
Adrien Rouault
Institut Cochin 1 INSERM U1016, CNRS UMR 8104 Université Paris Cité, Paris, France
15 shared publications
Amadeu Llebaria
MCS, Laboratory of Medicinal Chemistry and Synthesis, Institute of Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain
15 shared publications
Anna Llebaria-Fabrias
Institut Cochin 1 INSERM U1016, CNRS UMR 8104 Université Paris Cité, Paris, France
15 shared publications
Armelle Prévost-Blondel
INSERM, U1016, Institut Cochin, Paris, France
15 shared publications
Arthur Herrmann
Institut Cochin 1 INSERM U1016, CNRS UMR 8104 Université Paris Cité, Paris, France
15 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 17 June 2026
- Published by Elsevier in Journal of Investigative Dermatology
IL4I1+ Macrophage Accumulation in Advanced Cutaneous T-Cell Lymphomas Suggests a Role in Tumor Immune Escape
by Oumeslakht Loubna, Barbara Papouin, C. Lamaison, S. Ingen-Housz-Oro, N. Martin, S. Ben Mkaddem, V. Molinier-Frenkel, F. Castellano, N. Ortonne
Website
Google Scholar
- 17 June 2026
- Published by Elsevier in Journal of Investigative Dermatology
Open Access
IL4I1+ Macrophage Accumulation in Advanced Cutaneous T-Cell Lymphomas Suggests a Role in Tumor Immune Escape
by Oumeslakht Loubna, Barbara Papouin, C. Lamaison, S. Ingen-Housz-Oro, N. Martin, S. Ben Mkaddem, V. Molinier-Frenkel, F. Castellano, N. Ortonne
Open Access
Website
Google Scholar
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression
by Malvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, Adrien Rouault, Arthur Herrmann, Renée Lengagne, Masashi Kato, Flavia Castellano, Valérie Molinier-Frenkel, Amadeu Llebaria, et al.
Website
Google Scholar
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S3 from Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression
by Malvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, Adrien Rouault, Arthur Herrmann, Renée Lengagne, Masashi Kato, Flavia Castellano, Valérie Molinier-Frenkel, Amadeu Llebaria, et al.
Open Access
Website
Google Scholar
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression
by Malvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, Adrien Rouault, Arthur Herrmann, Renée Lengagne, Masashi Kato, Flavia Castellano, Valérie Molinier-Frenkel, Amadeu Llebaria, et al.
Website
Google Scholar
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S2 from Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression
by Malvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, Adrien Rouault, Arthur Herrmann, Renée Lengagne, Masashi Kato, Flavia Castellano, Valérie Molinier-Frenkel, Amadeu Llebaria, et al.
Open Access
Website
Google Scholar
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S11 from Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression
by Malvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, Adrien Rouault, Arthur Herrmann, Renée Lengagne, Masashi Kato, Flavia Castellano, Valérie Molinier-Frenkel, Amadeu Llebaria, et al.
Website
Google Scholar
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S11 from Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression
by Malvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, Adrien Rouault, Arthur Herrmann, Renée Lengagne, Masashi Kato, Flavia Castellano, Valérie Molinier-Frenkel, Amadeu Llebaria, et al.
Open Access
Website
Google Scholar
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S12 from Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression
by Malvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, Adrien Rouault, Arthur Herrmann, Renée Lengagne, Masashi Kato, Flavia Castellano, Valérie Molinier-Frenkel, Amadeu Llebaria, et al.
Website
Google Scholar
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S12 from Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression
by Malvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, Adrien Rouault, Arthur Herrmann, Renée Lengagne, Masashi Kato, Flavia Castellano, Valérie Molinier-Frenkel, Amadeu Llebaria, et al.
Open Access
Website
Google Scholar
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S8 from Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression
by Malvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, Adrien Rouault, Arthur Herrmann, Renée Lengagne, Masashi Kato, Flavia Castellano, Valérie Molinier-Frenkel, Amadeu Llebaria, et al.
Website
Google Scholar
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S8 from Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression
by Malvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, Adrien Rouault, Arthur Herrmann, Renée Lengagne, Masashi Kato, Flavia Castellano, Valérie Molinier-Frenkel, Amadeu Llebaria, et al.
Open Access
Website
Google Scholar
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S9 from Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression
by Malvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, Adrien Rouault, Arthur Herrmann, Renée Lengagne, Masashi Kato, Flavia Castellano, Valérie Molinier-Frenkel, Amadeu Llebaria, et al.
Website
Google Scholar
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S9 from Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression
by Malvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, Adrien Rouault, Arthur Herrmann, Renée Lengagne, Masashi Kato, Flavia Castellano, Valérie Molinier-Frenkel, Amadeu Llebaria, et al.
Open Access
Website
Google Scholar
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression
by Malvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, Adrien Rouault, Arthur Herrmann, Renée Lengagne, Masashi Kato, Flavia Castellano, Valérie Molinier-Frenkel, Amadeu Llebaria, et al.
Website
Google Scholar
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S7 from Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression
by Malvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, Adrien Rouault, Arthur Herrmann, Renée Lengagne, Masashi Kato, Flavia Castellano, Valérie Molinier-Frenkel, Amadeu Llebaria, et al.
Open Access
Website
Google Scholar
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression
by Malvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, Adrien Rouault, Arthur Herrmann, Renée Lengagne, Masashi Kato, Flavia Castellano, Valérie Molinier-Frenkel, Amadeu Llebaria, et al.
Website
Google Scholar
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S5 from Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression
by Malvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, Adrien Rouault, Arthur Herrmann, Renée Lengagne, Masashi Kato, Flavia Castellano, Valérie Molinier-Frenkel, Amadeu Llebaria, et al.
Open Access
Website
Google Scholar
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression
by Malvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, Adrien Rouault, Arthur Herrmann, Renée Lengagne, Masashi Kato, Flavia Castellano, Valérie Molinier-Frenkel, Amadeu Llebaria, et al.
Website
Google Scholar
- 4 March 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S6 from Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression
by Malvina Seradj, Saniya Kari, Anna Llebaria-Fabrias, Adrien Rouault, Arthur Herrmann, Renée Lengagne, Masashi Kato, Flavia Castellano, Valérie Molinier-Frenkel, Amadeu Llebaria, et al.

Show all